Glenmark Pharmaceuticals, based in Elmwood Park, New Jersey, issued the recall for several lots of Ziac (bisoprolol fumarate and hydrochlorothiazide) tablets. 

By Joe Lombardi From Daily Voice

A widely used prescription medication for high blood pressure is being recalled after more than 11,100 bottles were found to be at risk for cross-contamination with a cholesterol drug, according to the FDA.

Glenmark Pharmaceuticals, based in Elmwood Park, New Jersey, issued the recall for several lots of Ziac (bisoprolol fumarate and hydrochlorothiazide) tablets. 

The affected batches were manufactured in India and have expiration dates ranging from November 2025 to May 2026. The recall includes 30-, 100-, and 500-count bottles of various dosages:

  • 30-tablet bottles (NDC-68462-878-30), Lot 17232401, exp. 11/2025
  • 100-tablet bottles (NDC-68462-878-01), Lot 17232401, exp. 11/2025
  • 500-tablet bottles (NDC-68462-878-05), Lot 17232401, exp. 11/2025 and Lot 17240974, exp. 05/2026

The FDA classified this as a Class III recall, meaning use of the product is not likely to cause adverse health consequences. Testing detected trace amounts of ezetimibe, a cholesterol-lowering drug, in reserve samples—though no related injuries or adverse reactions have been reported so far.

Patients are advised to check their medication bottles for the recalled lot numbers. If you have a recalled bottle, consult your pharmacist or doctor about a replacement. Do not stop taking your blood pressure medication without consulting a healthcare provider, as untreated hypertension increases the risk of heart attack and stroke.

This recall comes on the heels of other recent blood pressure drug recalls. In November 2025, Teva recalled over 580,000 prazosin capsules due to quality issues, and earlier, spironolactone tablets were pulled for possible aluminum contamination.

Check back to Daily Voice for updates.